Olopatadine Hydrochloride 70069-0491-01
- Manufacturer
- Somerset Therapeutics, Llc
- Dosage Form
- Solution/ Drops
- Route
- Ophthalmic
- Product Type
- Human Otc Drug
- Marketing Start
- December 20, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA215006
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olopatadine Hydrochloride | 2 mg/mL |
Drug Class
Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Selected Package
70069-0491-01Selected2.5 mL in 1 BOTTLE, PLASTIC (70069-491-01)